Austin Speier, chief strategy officer at Click Therapeutics, discusses the company’s expanded partnership with Boehringer Ingelheim.
Q&A: How pharma partnerships could benefit digital therapeutics companies

Austin Speier, chief strategy officer at Click Therapeutics, discusses the company’s expanded partnership with Boehringer Ingelheim.